Hematopoietic Progenitor Cells, Cord (HPC-C) (Hemacord)
Hematopoietic Progenitor Cells, Cord (HPC-C) is an FDA-licensed reference biologic from New York Blood Center, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2011
Reference approved
Reference product
Hemacord Hematopoietic Progenitor Cells, Cord (HPC-C)
New York Blood Center, Inc.
- Approved
- Nov 10, 2011
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Hematopoietic Progenitor Cells, Cord (HPC-C), in chronological order.
Reference approval
Approval date of the reference Hematopoietic Progenitor Cells, Cord (HPC-C) product.
14 yr 9 mo ago
Frequently asked questions
Are there biosimilars approved for Hematopoietic Progenitor Cells, Cord (HPC-C) (Hemacord)?
No 351(k) biosimilars or interchangeable biosimilars referencing Hematopoietic Progenitor Cells, Cord (HPC-C) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.